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at low dose rates. Ppol maximum variation, for fields up to 
10x10 cm2, was 0.8% while Pion showed a 0.4% maximum 
difference for the examined fields. The comparison between 
OF acquired with A26 and diode showed a mean difference of 
0.7%; an exception is given by 1x1 cm2 field, in which a 7.7% 
discrepancy between detectors was noticed. Profiles scanned 
by A26 were in agreement with diode (0.5 mm maximum 
penumbra variation for 2x2 cm2 field). The comparison with 
profiles acquired by A1SL showed a 0.2 mm maximum 
penumbra difference for 3x3 cm2 field. A26 Full Width at Half 
Maximum (FWHM) measurements showed a 0.4 mm (for 3x3 
cm2 field) and 0.2 mm (for 1x1 and 2x2 cm2 fields) maximum 
difference compared to the results obtained by diode and 
A1SL respectively. As regards PDD, a good agreement was 
achieved between A26 and both diode and A1SL readings for 
2x2 and 3x3 cm2 fields (maximum difference 1.7%); for 1x1 
cm2 field (as shown in figure), as depth increased, a not 
negligible difference (up to 10%) was observed between A26 
and A1SL while the comparison with diode confirmed the 
good accordance shown previously. 
 
 
 
Conclusions: Not negligible differences between detectors 
were observed. Montecarlo correction factors for diode might 
explain the OF discrepancy with A26, while the A1SL bigger 
collecting volume could justify the variation observed in 1x1 
cm2 field PDD. Due to the lack of a gold standard detector for 
small field dosimetry, the previous measurements showed the 
reliability of A26 as detector for small fields. 
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Purpose/Objective: Contemporary radiotherapy approaches 
widely employ ‘non standard’ photon beams raising 
unprecedented challenges for absolute dose determination. 
In particular, standard reference dosimetry for small fields 
used in stereotactic radiosurgery treatments is substantially 
unfeasible. The implementation of new technologies for 
dosimetry is mandatory. The aim of this work is to 
characterize Exradin W1, a plastic scintillation detector 
manufactured by Standard Imaging, Inc. that seems to be 
promising in term of water equivalence, spatial resolution, 
dose rate and energy dependence for small field dosimetry 
purpose. 
Materials and Methods: Exradin W1 was irradiated in vertical 
position (axis parallel to beam axis) in a water phantom with 
6MV and 10 MV photon beams produced by a Varian 
Accelerator. Beam stability during irradiation was monitored 
with a PTW Semiflex Ionization Chamber (IC). W1 dose 
calibration for both energies was carried on at 10 cm depth 
in a 10x10cm2 field, in two different condition of irradiated 
optical fiber length. Dose linearity was investigated at a dose 
rate of 300MU/min ranging from 4 to 1000 MU in 10x10 cm2 
field. Dose-rate dependence was also studied varying from 
100 to 600 MU/min. The detector response depending on 
gantry orientation was tested in a 5x5cm2 field, at 10° step 
angles from 340°to 40°. Relative output factors (ROF) were 
measured at 10cm depth for both energies with W1, PTW 
PinPoint IC and PTW microdiamond detector up to 0.4x.04cm2 
field. Results were also compared with Pinnacle3 and 
RayStation TPSs calculated values. 
Results: Detector dose response showed a optimal linearity 
both for 6MV and 10MV, less than 0.5% up to 4MU and 1% for 
MU<4 but due to accelerator behavior. Regarding dose-rate 
dependence a standard deviation of 0.3% was observed 
among measurements performed in the range all dose-rates 
tested. Detector response showed a not negligible 
dependence on the length of fiber irradiated, observed both 
in calibration setup and during measurements at different 
gantry angle.  Output factor measured with the 3 detectors 
showed a maximum difference of 1% for the 1x1cm2 field. A 
poorer agreement was found for smaller field dimension. As 
expected, the same trend was observed comparing W1 
detector measured ROF with calculated values, that is, a 
difference less than 0.5% up to 1x1cm2 and worse beyond. 
Conclusions: Exradin W1 is a new detector that seems to 
introduce a minimum perturbation of the beam fluence. It is 
fast in data collection and easy to set up and manage. It 
show a good behavior in term of dose linearity and dose rate 
independence.  
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Purpose/Objective: Methyl Viologen (MV) is a chemical 
dosimeter historically used in pulsed radiolysis studies since 
it gives a sub-microsecond response to the delivered dose. 
MV is also reported to be dose-rate independent up to ultra-
high (≥ 106 Gy/s) dose-rates. The recent interest into using 
MV as a clinical dosimeter in radiotherapy is coupled with 
promising new radiotherapy techniques operating at these 
dose-rates, e.g. Flash irradiation and synchrotron radiation 
therapy. The purpose of this study is to characterize MV as a 
clinical dosimeter and to reveal its potential use in routine 
measurements at a radiotherapy department. 
Materials and Methods: When ionizing radiation interacts 
with a MV solution it produces radicals, which display a 
characteristic blue color. This occurs as visible light is 
strongly absorbed, with absorbance peaks at wavelengths (λ) 
of around 395 nm and 603 nm. Consequently, the absorbed 
dose by a MV solution is readily determined by measuring the 
optical density (absorbance) at those particular wavelengths 
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with spectrophotometry. Hence, the absorbed dose (D) is 
given by: 
D = Aλ · cλ  
where Aλ is the absorbance (λ is 395 or 603 nm) and cλ is a 
constant which depends on the radiolytic yield (i.e. the 
amount of radicals created per absorbed joule), the density, 
and the molar extinction coefficient of the solution, as well 
as the path length of the light through the solution.  
The reproducibility of the MV dose measurements was 
assessed by irradiating samples of MV solution (introduced in 
optical cuvettes) with 1000 monitor units (MU) from a clinical 
electron beam (4 MeV at an Elekta Synergy) and repeating 
this process for 20 different solutions. The linearity response 
was checked by delivering 10 – 10 000 MU to the solution, 
while the dose-rate dependence was investigated at normal 
clinical dose-rates by delivering 1 000 MU with varying dose-
rate 25 – 430 MU/min. 
Results: Our MV dose measurements show an acceptable 
level of reproducibility with a standard deviation for the 20 
measurements of 1.8 % for both wavelengths. The dosimeter 
has a linear dose-response relationship between 500 – 7 000 
MU (≈ 5 – 70 Gy), and is clinically usable (but not linear) down 
to 100 MU, see Figure 1.  
 
 
Our results show a small dose-rate dependence of the MV 
response, specifically an increase of the response with higher 
dose-rate. This behavior is most likely due to the fading of 
the signal that occurs over time and starts to become a 
considerable factor for long irradiation sessions.  
Conclusions: The results of our study show that MV is useable 
as a clinical dosimeter within radiotherapy. Although its 
characteristics cannot rival those of ion-chambers or diodes 
at normal dose-rates, its reported dose-rate independence up 
to high dose-rates makes it of clinical interest. The 
characteristics of MV can make it a vital component in taking 
promising experimental radiotherapy techniques like high 
dose rate irradiation and synchrotron radiation therapy to 
clinical trials. 
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Purpose/Objective: To present a simplified methodology for 
quantitatively assessing the effects of spatial dose delivery 
inaccuracies on DVHs and to highlight the dependence of the 
treatment outcome and patient safety on small spatial dose 
delivery errors in an hypophysis treatment case. 
Materials and Methods: The planning-CT scans, the 
RStructure dicom-RT file and the Treatment Planning System 
(TPS) calculated RDose dicom-RT file of an hypophysis patient 
treatment were imported to the open source software 3D-
slicer. Spatial dose delivery errors, ranging from 1 to 3 mm in 
all Cartesian directions, were systematically introduced to 
the TPS calculated dose dataset (RDose). To achieve this, the 
RDose dataset volume was manually moved along the x, y and 
z axes (antero-posterior, left-right and cranio-caudal 
directions respectively) while keeping spatially stationary the 
planning-CT scans and RStructure datasets. The DVHs, Dmean, 
Dmin. Dmax, V50.4 and D95% for the PTV, brainstem, right optic 
nerve and left optic nerve were calculated for the nominal 
dose delivery scenario, as well as for various simulation 
scenarios representing different spatial dose delivery errors.  
Results: For the brain tumor radiotherapy case studied 
(hypophysis), a relatively small spatial dose delivery error of 
1 mm in each axis resulted in minor DVH alterations for all 
structures. Contrarily, the worst case scenario investigated, 
i.e., 3 mm spatial dose delivery error in each axis, resulted in 
important DVH alterations for the PTV and the organs at risk. 
In the latter scenario, PTV D95% was reduced by about 18%, 
while right optic nerve D95% was increased by over 30%. 
Acquired results suggest that cranio-caudal spatial errors 
induce the more intense DVH alterations. The incorporated 
table presents the calculated values of Dmean, Dmin. Dmax, V50.4 
and D95% for all studied structures and two of the simulated 
scenarios with spatial delivery inaccuracies, whilst 
corresponding PTV DVHs are depicted in the included Figure 
(solid, dashed and dotted lines represent the scenarios of 0, 
1 and 3 mm spatial errors in each axis, respectively). 
 
